Jazz Pharmaceuticals (JAZZ) FCF Margin (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly FCF Margin of 30.97% for Q1 2026, down 1691.0% year-over-year from 1.95% in Q1 2025, and down 68.07% quarter-over-quarter from 96.99% in Q4 2025.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) FCF Margin (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' FCF Margin history runs 17 years deep, the most recent figure standing at 30.97% for Q1 2026.
- In Q1 2026, FCF Margin fell 1691.0% year-over-year to 30.97%; the TTM figure through Mar 2026 stood at 27.0% (down 1051.0% YoY), while the FY2025 annual figure was 30.39%, down 298.0% from the prior year.
- FCF Margin for Q1 2026 stood at 30.97%, down from 96.99% in the prior quarter.
- The five-year high for FCF Margin was 96.99% in Q4 2025, with the low at 33.98% in Q3 2025.
- The 5-year median for FCF Margin is 31.5% (2023), against an average of 31.37%.
- Peak annual rise in FCF Margin reached 6158 bps in 2025, while the deepest fall reached 7075 bps in 2025.
- Jazz Pharmaceuticals' FCF Margin stood at 34.73% in 2022, then sank by 48 bps to 17.91% in 2023, then surged by 98 bps to 35.41% in 2024, then soared by 174 bps to 96.99% in 2025, then slumped by 68 bps to 30.97% in 2026.
- Business Quant data shows JAZZ's FCF Margin at 30.97% in Q1 2026, 96.99% in Q4 2025, and 33.98% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Jazz Pharmaceuticals | 15.60 Bn | 13.98 Bn | 1.09 Bn | 34.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.40% |
| Mar 31, 2026 | 30.97% |
| Dec 31, 2025 | 30.26% |
| Sep 30, 2025 | 42.15% |
| Jun 30, 2025 | -72.24% |
| Mar 31, 2025 | 46.32% |
| Dec 31, 2024 | 35.41% |
| Sep 30, 2024 | 36.77% |
| Jun 30, 2024 | 31.67% |
| Mar 31, 2024 | 28.86% |
| Dec 31, 2023 | 16.23% |
| Sep 30, 2023 | 30.78% |
| Jun 30, 2023 | 30.65% |
| Mar 31, 2023 | 34.85% |
| Dec 31, 2022 | 34.21% |
| Sep 30, 2022 | 44.96% |
| Jun 30, 2022 | 31.17% |
| Mar 31, 2022 | 24.17% |
| Dec 31, 2021 | 18.71% |
| Sep 30, 2021 | 31.71% |